| Literature DB >> 6111672 |
D B Longmore, J G Bennett, P M Hoyle, M A Smith, A Gregory, T Osivand, W A Jones.
Abstract
In a double-blind trial prostacyclin was given to 12 of 23 patients undergoing coronary vein grafting. The treatment group showed a preservation of platelet number and function, with a halving of blood loss in the first 18 h postoperatively. The heparin sparing effect of prostacyclin was confirmed, as were the vasodilator effects which were not troublesome.Entities:
Mesh：
Substances：
Year: 1981 PMID： 6111672 DOI： 10.1016/s0140-6736(81)92680-5
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321